Evidence-Based Benefits
- Inflammatory marker reduction — a 2020 meta-analysis (Haghighatdoost and Hariri, 11 RCTs, n=763) found green tea supplementation significantly reduced CRP levels, particularly in doses ≥500mg catechins for ≥8 weeks
- NF-kB inhibition — EGCG directly inhibits IKK activation, preventing NF-kB nuclear translocation and suppressing transcription of TNF-alpha, IL-1beta, IL-6, and COX-2 genes
- Antioxidant defense — EGCG scavenges reactive oxygen species and upregulates Nrf2-mediated antioxidant enzymes (SOD, catalase, HO-1), reducing oxidative stress that drives chronic inflammation
- Metabolic improvement — a 2018 meta-analysis (Lin et al., 22 RCTs, n=1,584) found green tea catechins significantly reduced fasting glucose, insulin, and HbA1c in type 2 diabetes patients
- Fat oxidation — EGCG and caffeine synergistically increase fat oxidation by 10-16%, with a 2009 meta-analysis (Hursel et al.) confirming small but significant effects on body weight and fat mass